Updated on 2024/07/28

Information

 

写真a

 
TANAKA YOSHIHIRO
 
Organization
Kyushu University Hospital Department of Advanced Molecular and Cell Therapy Assistant Professor
School of Medicine Department of Medicine(Joint Appointment)
Title
Assistant Professor
Contact information
メールアドレス
Tel
0926425102
Profile
特定細胞加工物製造施設(分子・細胞調製センター(MCPC))の施設管理・運営
External link

Papers

  • A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors. Reviewed International journal

    Hijikata Y, Okazaki T, Tanaka Y, Murahashi M, Yamada Y, Yamada K, Takahashi A, Inoue H, Kishimoto J, Nakanishi Y, Oda Y, Nakamura Y, Tani K.

    PLoS One   13 ( 1 )   1 - 21   2018.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0187878

  • Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors. Reviewed International journal

    Murahashi M, Hijikata Y, Yamada K, Tanaka Y, Kishimoto J, Inoue H, Marumoto T, Takahashi A, Okazaki T, Takeda K, Hirakawa M, Fujii H, Okano S, Morita M, Baba E, Mizumoto K, Maehara Y, Tanaka M, Akashi K, Nakanishi Y, Yoshida K, Tsunoda T, Tamura K, Nakamura Y, Tani K.

    Clinical Immunology   166 ( 48 )   48 - 58   2016.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.clim.2016.03.015

  • TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells. Reviewed International journal

    Narusawa M, Inoue H, Sakomoto C, Matsumura Y, Takahashi A, Inoue T, Watanabe A, Miyamoto S, Miura Y, Hijikata Y, Tanaka Y, Inoue M, Takayama K, Okazaki T, Hasagawa M, Nakanishi Y, Tani K.

    Cancer Immunol Res.   2 ( 6 )   568 - 580   2014.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1158/2326-6066.CIR-13-0143

  • 固形腫瘍に対する新規免疫療法の開発―当科における第I相臨床試験の現状― Reviewed

    土方 康基, 村橋(伊賀) 睦了, 岡崎 利彦, 田中 芳浩, 大平 公亮, 岡野 慎士, 久野 晃聖, 高橋 淳, 丸本 朋稔, 井上 博之, 谷 憲三朗

    臨床血液   53 ( 5 )   487 - 492   2012.6

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.11406/rinketsu.53.487

  • 抗腫瘍免疫療法における新戦略-New strategies of immunetherapy targeting malignancy- Reviewed

    村橋(伊賀)睦了, 土方 康基, 末廣 陽子, 田中 芳浩, 下田 真也, 丸本 朋稔, 岡崎 利彦, 吉田浩二, 角田 卓也, 谷 憲三朗.

    臨床血液   51 ( 11 )   1654 - 1660   2010.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.11406/rinketsu.51.1654

  • Remarkably high inhibitory effects of docosahexaenoic acid incorporated into hybrid liposomes on the growth of tumor cells along with apoptosis. Reviewed International journal

    Tanaka Y, Goto K, Matsumoto Y, Ueoka R.

    International Journal of Pharmaceutics   359 ( 1-2 )   264 - 271   2008.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ijpharm.2008.03.045.

▼display all

Professional Memberships

  • The Japanese Society for Regenerative Medicine

Research Projects

  • 医療技術実用化総合促進事業

    2018.4 - 2019.3

      More details

    Authorship:Coinvestigator(s) 

Outline of Social Contribution and International Cooperation activities

  • 再生医療に関する使用実績を増やし、再生医療の普及・発展を目指す。

Notable Clinical Activities

  • 保険診療に使用する再生医療等製品の製造・品質業務を継続的に実施する。